Stocks in the United States | Brain Regeneration Technology (RGC.US) rose by more than 18%, with a total market value exceeding $4.8 billion.

According to the Securities Times APP, on Wednesday, the stock price of ReNeuron Group (RGC.US) surged, rising more than 18% to $370.43 as of press time. Currently, the market value of the stock exceeds $4.8 billion. ReNeuron Group is a biotechnology company focused on traditional Chinese medicine for the early treatment of neurological cognitive disorders and degenerative diseases. The company was established on October 30, 2014, registered in the Cayman Islands, and operates mainly through its subsidiary in Hong Kong.